Characterization of Potential Drug Targets Farnesyl Diphosphate Synthase and Geranylgeranyl Diphosphate Synthase in Schistosoma mansoni

Schistosomiasis affects over 200 million people worldwide, with over 200,000 deaths annually. Currently, praziquantel is the only drug available against schistosomiasis. We report here that Schistosoma mansoni farnesyl diphosphate synthase (SmFPPS) and geranylgeranyl diphosphate synthase (SmGGPPS) a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ziniel, Peter D., Desai, Janish, Cass, Cynthia L., Gatto, Craig, Oldfield, Eric, Williams, David L.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2013
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837879/
https://ncbi.nlm.nih.gov/pubmed/24041901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00699-13
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires